Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the company announced it would present new data from eight studies at the 2025 San Antonio ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

A committee has recommended an expansion of the indication for Winrevair, an approved injection therapy for adults with PAH, ...

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

Pivot Bio, one of the world's leading innovative agtech companies, today announced six seasoned professionals have joined its senior management team. They ...

The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy ...

NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026. FORT ...

SUMO E1 inhibition inhibits ocular lens fibrosis by suppressing TGFβ2-induced SMAD4 SUMOylation Fibrotic cataracts are a ...

Neoliensinine improves T-cell malignancy therapy by inducing TUBA1B-mediated lysosomal degradation of STING T-cell ...

Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.